Reply to Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3

Autor:	Hikaru Sugimoto, William D. Carlson, Valerie S. LeBleu, Raghu Kalluri, Keizo Kanasaki, Björn Tampe, Dattatreyamurty Bosukonda, Mary Rusckowski, Peter Keck, Désirée Tampe, Gangadhar Taduri, Philippe Bey, Wibke Bechtel, Michael Zeisberg, Hirokazu Okada
Rok vydání:	2013
Předmět:	Agonist medicine.medical_specialty animal structures medicine.drug_class Bone morphogenetic protein 8A Kidney Tropomyosin receptor kinase C General Biochemistry Genetics and Molecular Biology 03 medical and health sciences 0302 clinical medicine Transforming Growth Factor beta Internal medicine medicine Animals Regeneration Bone morphogenetic protein receptor Smad3 Protein 030304 developmental biology 0303 health sciences Chemistry Kidney metabolism General Medicine Bone Morphogenetic Protein Receptors Cell biology BMPR1B BMPR2 Endocrinology Mechanism of action embryonic structures Bone Morphogenetic Proteins medicine.symptom Peptides hormones hormone substitutes and hormone antagonists 030217 neurology & neurosurgery
Zdroj:	Nature medicine. 19(7)
ISSN:	1546-170X
Popis:	Reply to Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4154670c4d60a0750e29d5fe5e1e1c80 https://pubmed.ncbi.nlm.nih.gov/23836213 Zobrazit plný text záznamu Plný text ve formátu PDF